Harout Semerjian
Chief Executive Officer bij GLYCOMIMETICS, INC.
Vermogen: 75 000 $ op 31-03-2024
Profiel
Harout Semerjian is the President, Chief Executive Officer & Director at GlycoMimetics, Inc. He was previously the President, Chief Executive Officer & Director at Immunomedics, Inc. for a brief period in 2020.
Before that, he was the Chief Commercial Officer & Executive VP at Ipsen SA from 2018 to 2020 and the Managing Director at Ipsen Pharma SAS.
Semerjian holds an MBA from both Queen's University and Cornell University, as well as an undergraduate degree from Lebanese American University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GLYCOMIMETICS, INC.
0.04% | 12-01-2024 | 25 000 ( 0.04% ) | 75 000 $ | 31-03-2024 |
Actieve functies van Harout Semerjian
| Bedrijven | Functie | Begin |
|---|---|---|
| GLYCOMIMETICS, INC. | Chief Executive Officer | 06-08-2021 |
Eerdere bekende functies van Harout Semerjian
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOMEDICS, INC. | Chief Executive Officer | 27-05-2020 |
| IPSEN | Corporate Officer/Principal | 01-04-2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | - |
Opleiding van Harout Semerjian
| Queen's University | Masters Business Admin |
| Cornell University | Masters Business Admin |
| Lebanese American University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IPSEN | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
